194 related articles for article (PubMed ID: 21840164)
1. Combined medication and cognitive therapy for generalized anxiety disorder.
Crits-Christoph P; Newman MG; Rickels K; Gallop R; Gibbons MB; Hamilton JL; Ring-Kurtz S; Pastva AM
J Anxiety Disord; 2011 Dec; 25(8):1087-94. PubMed ID: 21840164
[TBL] [Abstract][Full Text] [Related]
2. Combined medication and CBT for generalized anxiety disorder with African American participants: reliability and validity of assessments and preliminary outcomes.
Markell HM; Newman MG; Gallop R; Gibbons MB; Rickels K; Crits-Christoph P
Behav Ther; 2014 Jul; 45(4):495-506. PubMed ID: 24912462
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of venlafaxine extended-release capsules in nondepressed outpatients with generalized anxiety disorder: A 6-month randomized controlled trial.
Gelenberg AJ; Lydiard RB; Rudolph RL; Aguiar L; Haskins JT; Salinas E
JAMA; 2000 Jun; 283(23):3082-8. PubMed ID: 10865302
[TBL] [Abstract][Full Text] [Related]
4. Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder.
Meoni P; Salinas E; Brault Y; Hackett D
J Clin Psychiatry; 2001 Nov; 62(11):888-93. PubMed ID: 11775049
[TBL] [Abstract][Full Text] [Related]
5. Remission rates with venlafaxine extended release in Greek outpatients with generalized anxiety disorder. A double-blind, randomized, placebo controlled study.
Nimatoudis I; Zissis NP; Kogeorgos J; Theodoropoulou S; Vidalis A; Kaprinis G
Int Clin Psychopharmacol; 2004 Nov; 19(6):331-6. PubMed ID: 15486518
[TBL] [Abstract][Full Text] [Related]
6. Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release.
Rickels K; Etemad B; Khalid-Khan S; Lohoff FW; Rynn MA; Gallop RJ
Arch Gen Psychiatry; 2010 Dec; 67(12):1274-81. PubMed ID: 21135327
[TBL] [Abstract][Full Text] [Related]
7. Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder.
Davidson JR; DuPont RL; Hedges D; Haskins JT
J Clin Psychiatry; 1999 Aug; 60(8):528-35. PubMed ID: 10485635
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment strategies in anxiety disorders.
Allgulander C; Hirschfeld RM; Nutt DJ
Psychopharmacol Bull; 2002; 36 Suppl 2():79-92. PubMed ID: 12490824
[TBL] [Abstract][Full Text] [Related]
9. The effects of venlafaxine and cognitive behavioral therapy alone and combined in the treatment of co-morbid alcohol use-anxiety disorders.
Ciraulo DA; Barlow DH; Gulliver SB; Farchione T; Morissette SB; Kamholz BW; Eisenmenger K; Brown B; Devine E; Brown TA; Knapp CM
Behav Res Ther; 2013 Nov; 51(11):729-35. PubMed ID: 24055681
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of extended-release venlafaxine in nondepressed outpatients with generalized anxiety disorder.
Rickels K; Pollack MH; Sheehan DV; Haskins JT
Am J Psychiatry; 2000 Jun; 157(6):968-74. PubMed ID: 10831478
[TBL] [Abstract][Full Text] [Related]
11. Venlafaxine ER as a treatment for generalized anxiety disorder in older adults: pooled analysis of five randomized placebo-controlled clinical trials.
Katz IR; Reynolds CF; Alexopoulos GS; Hackett D
J Am Geriatr Soc; 2002 Jan; 50(1):18-25. PubMed ID: 12028242
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of venlafaxine, extended release formulation, in the short-term and long-term treatment of generalized anxiety disorder: results of a survival analysis.
Montgomery SA; Mahé V; Haudiquet V; Hackett D
J Clin Psychopharmacol; 2002 Dec; 22(6):561-7. PubMed ID: 12454555
[TBL] [Abstract][Full Text] [Related]
13. Generalized anxiety disorder: raising the expectations of treatment.
Allgulander C; Sheehan DV
Psychopharmacol Bull; 2002; 36 Suppl 2():68-78. PubMed ID: 17450651
[TBL] [Abstract][Full Text] [Related]
14. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.
Sheehan DV
J Clin Psychiatry; 1999; 60 Suppl 22():23-8. PubMed ID: 10634352
[TBL] [Abstract][Full Text] [Related]
15. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
Bose A; Korotzer A; Gommoll C; Li D
Depress Anxiety; 2008; 25(10):854-61. PubMed ID: 18050245
[TBL] [Abstract][Full Text] [Related]
16. Venlafaxine in the treatment of anxiety disorders.
Katzman M
Expert Rev Neurother; 2004 May; 4(3):371-81. PubMed ID: 15853535
[TBL] [Abstract][Full Text] [Related]
17. Treatment of generalized anxiety disorder.
Gorman JM
J Clin Psychiatry; 2002; 63 Suppl 8():17-23. PubMed ID: 12044104
[TBL] [Abstract][Full Text] [Related]
18. Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?
Baldwin DS; Schweizer E; Xu Y; Lyndon G
Eur Neuropsychopharmacol; 2012 Feb; 22(2):137-42. PubMed ID: 21839620
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine XR in the treatment of anxiety.
Hackett D
Acta Psychiatr Scand Suppl; 2000; (406):30-5. PubMed ID: 11131468
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of pregabalin versus venlafaxine in the treatment of generalized anxiety disorder: findings from a Spanish perspective.
Vera-Llonch M; Dukes E; Rejas J; Sofrygin O; Mychaskiw M; Oster G
Eur J Health Econ; 2010 Feb; 11(1):35-44. PubMed ID: 19506926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
